Please login to the form below

Not currently logged in


This page shows the latest Sotorasib news and features for those working in and with pharma, biotech and healthcare.

Amgen aims for first KRAS inhibitor approval in the US

Amgen aims for first KRAS inhibitor approval in the US

In October, Amgen revealed topline results from its phase 2 study of sotorasib in advanced NSCLC. ... In the phase 2 study, sotorasib demonstrated an objective response rate consistent with previously reported phase 1 data.

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs


Add my company

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

Want to give perfect client service? Tough luck, you’re human
In this article an ex-client of mine, Liz Skrbkova, and I explore the (unhelpful) pressures of trying to perfect the client-agency relationship...
WHITE PAPER: Why do men die younger?
It’s a commonly accepted fact that women outlive men. Wherever you live, there’s a good chance that men will die on average eight years earlier than women. Is this an...
3 tips to show patient diversity in your clinical trial materials
Here are some useful tips to help get your hands on authentically diverse stock photos....